“Back to the Future”: Developments in Immunotherapy with David Gandara, MD
Release Date: 12/12/2024
Equitable Representation in Clinical Trials with Nadine Spring, PhD
Oncology Overdrive
In this episode, host Shikha Jain, MD, speaks with Nadine Spring, PhD, about the importance of DEI in clinical care, driving positive social change forward and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Spring 0:20 • The interview 1:00 • Tell me about the journey that got you to where you are today? 1:18 • Can you tell me more about and your role there? 5:11 • Why does diversity and equitable representation in clinical trials and care matter? 6:23 • ...
info_outline
Finding fulfillment in medicine: Physician side gigs and exploring new avenues, with Navin Goyal, MD (Crossover with Physicianary)
Oncology Overdrive
In this special crossover episode with Physicianary, guest Navin Goyal, MD, and Physicianary host, Hansa Bhargava, MD, discuss side gigs in the health care space, encourage physicians to explore their fields of interest and talk about his book, Physician Underdog. • Intro 0:28 • Navin Goyal, MD 0:35 • You have done a lot to help Medicaid patients with your venture capital group, OFFOR Health. Can you tell us about that? 1:25 • What was the driver of your venture capital group? Was it access to care? 3:21 • Tell us...
info_outline
Pioneering Changes in Patient Advocacy with Kimberly Richardson
Oncology Overdrive
In this episode, host Shikha Jain, MD, speaks with Kimberly Richardson about driving changes in patient advocacy efforts, the importance of including DEI in cancer research and clinical trials and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Richardson 0:20 • The interview 1:15 • How did you get to where you are today as such a leader and advocate? 1:56 • Did you feel welcomed into this space when you started doing your advocacy work, or did you feel like it was an uphill battle?...
info_outline
Survivorship and Visual Storytelling with Anna Rathkopf
Oncology Overdrive
In this episode, host Shikha Jain, MD, speaks with Anna Rathkopf about the mental and physical toll of cancer treatment and survivorship, using photography to connect with patients and caregivers and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Rathkopf 0:20 • The interview 1:23 • How did you get into storytelling through photography around your cancer diagnosis and your caregiver experience? 1:46 • How did you navigate questions and challenges surrounding fertility during the...
info_outline
Diversity and Development in Hematology with Belinda Avalos, MD
Oncology Overdrive
In this episode, host Shikha Jain, MD, speaks with ASH president, Belinda Avalos, MD, about the importance of DEI practices in medicine, leading molecular medicine developments and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Avalos 0:18 • The interview 1:18 • How did you know you know you wanted to be a hematologist and how did you end up in this space doing the work you’re doing now? 1:47 • Jain and Avalos on the innovations and patient relationships in the field of HemOnc...
info_outline
The Role of Machine Learning in Clinical Trials with Damon Rasheed
Oncology Overdrive
In this episode, host Shikha Jain, MD, speaks with Opyl co-founder Damon Rasheed about using machine learning to better predict clinical trial outcomes, handling ethical concerns surrounding AI in health care and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Rasheed 0:20 • The interview 0:58 • How did you end up in the AI-powered medicine and clinical trials? 1:48 • What is Opyl, and what is TrialKey? 3:54 • Is TrialKey predominantly based in Australia or is it...
info_outline
Highlights from ASH 2024 (Meeting Mic Re-Release)
Oncology Overdrive
In this special crossover episode of Oncology Overdrive, we bring you Healio coverage from the ASH Annual Meeting and Exhibition, as well as Healio’s top headlines from the meeting. Gwen L. Nichols, MD, reviews a panel discussion on how hematologists and oncologists can best address patients’ concerns as AI’s role in medicine invariably expands. :24 Thomas G. Knight, MD, addresses financial toxicity for people with blood cancer. 6:29 Charles S. Abrams, MD, discusses results of the HIBISCUS trial and its implications for vaso-occlusive events. 16:30 Read the full coverage here: ...
info_outline
“Back to the Future”: Developments in Immunotherapy with David Gandara, MD
Oncology Overdrive
In this episode, host Shikha Jain, MD, speaks with David Gandara, MD, about how ctDNA and CAR-T cell therapies are transforming precision medicine, the importance of patient reported outcomes and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Gandara 0:19 • The interview 1:02 • Can you tell me a little more about what you are working on now? 1:25 • How did you get engaged with the community in Hawaii? 6:30 • What do you think is going to happen with ctDNA moving...
info_outline
Enhancing Clinical Trial Enrollment with Michel van Harten, MD
Oncology Overdrive
In this episode, host Shikha Jain, MD, speaks with Michel van Harten, MD, about creating better information systems for physicians and patients, how shared decision-making can improve drug development and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About van Harten 0:20 • The interview 1:00 • What was your journey to becoming a physician and beyond to where you are now? 1:24 • How did you learn the necessary skills to be an exceptional leader in this space? 2:51 • How...
info_outline
The Data Behind Precision Medicine with Melody Harris
Oncology Overdrive
In this episode, host Shikha Jain, MD, speaks with Melody Harris about the evolution of precision medicine, what physicians and companies can do to help patients better understand precision oncology and more. • Welcome to another exciting episode of Oncology Overdrive 0:14 • About Harris 0:20 • The interview 1:11 • Tell us about how you ended up in this niche role. 1:32 • How did you make the decision to move from practicing law to transitioning your career into this space? 3:56 • Jain and Harris...
info_outlineIn this episode, host Shikha Jain, MD, speaks with David Gandara, MD, about how ctDNA and CAR-T cell therapies are transforming precision medicine, the importance of patient reported outcomes and more.
• Welcome to another exciting episode of Oncology Overdrive 0:14
• About Gandara 0:19
• The interview 1:02
• Can you tell me a little more about what you are working on now? 1:25
• How did you get engaged with the community in Hawaii? 6:30
• What do you think is going to happen with ctDNA moving forward? 8:29
• Can you utilize ctDNA and minimal residual disease information to determine how long patients need to be on adjuvant therapy? 11:42
• How did you get into the ctDNA space? 15:06
• How do you see AI transforming health care beyond providing patients with more information and taking more ownership of their health? 18:28
• Can you tell us more about how a second opinion clinic works? How did this type of clinic develop and become part of what you do? 23:17
• What are some of your predictions as to what will happen in oncology care over the next ten to twenty years? 29:00
• If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 37:30
• How to contact Gandara 38:47
• Thanks for listening 39:10
David Gandara, MD, is a clinician-scientist and lung cancer specialist internationally recognized for his expertise in thoracic cancers, cancer drug development and biomarker development.
We’d love to hear from you! Send your comments/questions to Dr. Jain at [email protected]. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Dr. Gandara can be reached via email [email protected].
Disclosures: Jain reports no relevant financial disclosures. Gandara reports institutional research grants from Astex, Amgen and Genentech; institutional consulting for AstraZenica, Exact Sciences, Genentech, Guardant Health, IO Biotech and Oncohost; consulting for Adagene, Henlius USA, Foundation Medicine and Sanofi; serves on the advisory board of Abbvie, Janssen, Merck, Mirati, Regeneron and Revolution Medicine.